HOD Test Apps

OrthoHOD Pro App (for health professionals)

The Ortho-HOD Pro test is a combined test that encompasses 2 parts.

The first part is a test developed by Drs. Abram Hoffer and Humphrey Osmond that gauges perception and depression. Previously known as the HOD (Hoffer-Osmond Diagnostic) test, it is a series of 145 true/false questions designed to measure errors of perception.  The virtue of the HOD test rests in its ability to give an accurate snap-shot of a patient’s perceptual world in a time saving and convenient manner.

Results from the HOD test can either be used to determine the necessity for Orthomolecular Niacin (Vitamin B3) and Vitamin C supplementation (with a score of 30 or higher), or as an objective indicator for when cannabis and other cognitive impairing substances would be unsuitable for use as either a prescription or for recreational purposes.

The second part of the Ortho-HOD Pro test is a series of 39 true/false questions that give insight into areas of brain chemistry that may be deficient and can be corrected with targeted nutrition (also listed). These results also provide clues to physicians regarding lab workup requirements where necessary.  The following video explains the App in greater detail.

 

To download the Apple iPhone/iPad version of the app, go to the App Store on your device and search “OrthoHOD Pro”.

 

 

The OrthoHOD Pro App is available in the iTunes App store in both iPhone and iPad formats as well as on Google Play for Android formats.

The following is a list of the references and research that went into creating the HOD test.  Although it is not exhaustive, it will be updated regularly as further research comes to light.

OrthoHOD (for Harm Reduction)

Substance use and abuse is a growing problem in mental health. It has been given ample lip-service by health and government authorities, yet few tools have been made available to the public that will adequately address it in a constructive fashion.

The OrthoHOD App is a scaled down version for public use that will give the user an idea of whether or not cognition altering substances should be avoided.  The following video explains this version of the App:

 

 

To download the Apple iPhone/iPad version of the app, go to the App Store on your device and search “OrthoHOD”.

 

 

 

References:

Audette A. J., Johnson R. R., Anello F., Revisiting the Use of the Hoffer-Osmond Diagnostic Test in Mental Health., Journal of Orthomolecular Medicine, 2017, Vol. 32, No. 4.

Bisbee C., Mullaly R., Therapeutic uses of the Experiential World Inventory., Orthomolecular Psychiatry, Vol. 9, (1) 1980, 11-20.

Chiossone F., Hawkins D. R., Furfaro F., Runyon R. P., Schizophrenia: Responses to intensive hospital treatment as monitored by the HOD and OIT Tests.  Schizophrenia, 1969 (1), 233-242.

Green R. G., The HOD in general practice., Ch. 11 in Hoffer A., Kelm H., Osmond H., Clinical and Other Uses of the Hoffer-Osmond Diagnostic Test., Huntington, N.Y.: R.E. Krieger Publishing Co., 1975.

Goulding J., The Use of the Hoffer-Osmond Diagnostic Test (H.O.D.) in Relationship to Hypnosis., Journal of Orthomolecular Medicine, 1986, Vol. 1 (1) 17-23.

Hawkins D. R., Pauling L., Orthomolecular Psychiatry: Treatment of Schizophrenia., San Francisco, Calif.: W. H. Freeman & Co., 1973.

Hilsheimer von G., Levy A., Tucker J. T., Moore L. S., HOD-MMPI: A Comparison., Journal of Orthomolecular Psychiatry., 1977 (6) 8-17.

Hilsheimer von G., Tucker J. T., Moore L. S., Some physical and neuropsychological correlations of the HOD in delinquents., Journal of Orthomolecular Psychiatry, 1976 (5) 219-221.

Hoffer A., HOD scores for young subjects., Journal of Neuropsychiatry, 1963b (4) 279.

Hoffer A., Malvaria, Schizophrenia and the HOD test., International Journal of Neuropsychiatry, 1966d (2) 175-178.

Hoffer A., The Role of Perceptual Tests in Diagnosing Schizophrenia., Journal of Orthomolecular Medicine, 1991, Vol. 6, (1) 13-22.

Hoffer A., Kelm H., Inappropriate mood and schizophrenia., Schizophrenia, 1970 (2) 116-118.

Hoffer A., Osmond H., A card sorting test helpful in establishing prognosis. American Journal of Psychiatry, 1962b (118) 840-841.

Kelm H., The Hoffer-Osmond Diagnostic Test., Ch16, Hawkins D., Pauling L., Orthomolecular Psychiatry: Treatment of Schizophrenia., San Francisco, Calif.: W. H. Freeman & Co., 1973.

Kelm H., A Reply to the American Psychiatric Association Task Force on Megavitamin and Orthomolecular Therapy in Psychiatry: The HOD Test., Orthomolecular Psychiatry Vol. 7 (4) 1978, 258-262.

Kelm H., Callbeck M., Hoffer A., A short form of the Hoffer-Osmond Diagnostic Test., International Journal of Neuropsychiatry, 1967 (3) 489.

Kelm H., Chambers D. A., Hall R. W., An evaluation of the Hoffer-Osmond Diagnostic Test., Journal of Clinical Psychology, 1966 (22) 120-122.

Kelm H., Grunberg F., Hall R. W., A re-examination of the Hoffer-Osmond Diagnostic Test., International Journal of Neuropsychiatry, 1965 (1) 307-312.

Kelm H., Hoffer A., A revised score for the Hoffer-Osmond Diagnostic Test., Diseases of the Nervous System, 1965 (26) 790-791.

Kelm H., Hoffer A., Hall R. W., Reliability of the Hoffer-Osmond Diagnostic Test., Journal of Clinical Psychology, 1967 (23) 380-382.

Kowalson B., Metabolic Dysperception: its diagnosis and management in General Practice., Journal of Schizophrenia, 1967 (1) 200-203.

Marjerrison G., Irving D. G., Hrychuk W., Report comparing HOD and IMPS test results in a population of first admission patients., Saskatchewan Hospital, North Battleford, Sask., 1966.

Peters G., A study of Psychedelic drug users., Schizophrenia, 1970 (2) 103-108.

Pfeiffer C. C., Mailloux R., Forsythe L., The Schizophrenias, Ours to Conquer, Bio-Communications Press, 1988, Wichita, Kansas., ISBN: 0-942333-02-0.

Seidler S. L., HOD Test aids schizophrenics, Prevention, 1969, Sept., 117-120.

Silzer J. C. K., Marjerrison G., Irvine D. G., Observations on the clinical validity of the HOD and IMPS., Journal of Psychiatric Research, 1972 (9) 353-360.

Stewart C. N., Mahood M. C., A multiple group comparison of scores on the Hoffer-Osmond Diagnostic Test., Canadian Psychiatric Association Journal, 1963 (8) 133-137.

Tobin J. M., Treatment of schizophrenia with nicotinic acid: An overview., Journal of Schizophrenia, 1967 (1) 182-188.

Ward J. L., Treatment of neurotics and schizophrenics using clinical and HOD criteria., Journal of Schizophrenia, 1967 (1) 140-149.

 

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save

Save